[ADA2015]肥胖与非肥胖中国人群2型糖尿病的病理生理机制探讨
2015-06-07 来源:医脉通

医脉通,转载请务必注明出处。


2015年第75届美国糖尿病协会(ADA)科学年会正在美国波士顿召开。由北京朝阳医院内分泌科王广教授团队完成的一项研究在ADA2015年会最新研究壁报专场(Late Breaking Poster Session)上公布。该研究发现2型糖尿病的两大病理生理机制——β细胞功能异常和胰岛素抵抗在肥胖与非肥胖中国人群2型糖尿病进展中发挥着不同作用。以下是研究摘要译文。


β细胞功能障碍在2型糖尿病的发病中起着重要作用,而肥胖是胰岛素抵抗和2型糖尿病的主要原因。这项研究的目的是评估肥胖与非肥胖中国人从糖耐量正常到2型糖尿病的进展过程中,β细胞功能障碍和胰岛素抵抗的不同作用。


共有3254名年龄≥25岁的受试者参与研究,包括1,843名健康对照和1411名新诊断的2型糖尿病患者。所有受试者被分为非肥胖对照、肥胖对照、非肥胖2型糖尿病和肥胖2型糖尿病患者。


无论是对照组或2型糖尿病组,肥胖受试者稳态模型评估的胰岛素抵抗和β细胞功能(HOMA-IR和HOMA-β)均高于非肥胖者(P均<0.01)。


非肥胖2型糖尿病患者与非肥胖对照组患者相比,HOMA-IR较高,HOMA-β较低(P均<0.01)。


肥胖2型糖尿病患者的HOMA-β低于肥胖对照组患者(P<0.01),这两组之间HOMA-IR没有显著差异。


结论:β细胞功能下降,再加上持续的胰岛素抵抗,导致肥胖人群从糖耐量正常进展至2型糖尿病;而在非肥胖人群,胰岛β细胞功能下降是促进糖尿病发生的主要因素。


研究摘要

Abstract Number:313-LB
Title:The Different Contributions of ß-Cell Dysfunction and Insulin Resistance to the Progression of Type 2 Diabetes in Obese and Nonobese Chinese People 
Authors:JIA LIU, YING WANG, YANJIN HU, YUAN XU, SONG LENG, GUANG WANG, Beijing, China
Abstract:

β-cell dysfunction plays a prominent role in type 2 diabetes (T2D) etiology, and obesity is a major cause of insulin resistance and T2D. This study aimed to assess the different roles of β-cell dysfunction and insulin resistance in the progression from normal glucose tolerance to T2D in obese and non-obese Chinese people. A total of 3254 participants aged ≥ 25 years, including 1,843 healthy controls and 1,411 newly diagnosed T2D patients were recruited. All participants were categorized into the non-obese control, obese control, non-obese T2D and obese T2D groups. The obese subjects had higher homeostasis model assessment of insulin resistance and β-cell function (HOMA-IR and HOMA-β) than the non-obese ones, whether in the control group or the T2D group (all P <0.01). Higher HOMA-IR and lower HOMA-β were observed in non-obese T2D patients when compared with non-obese controls (all P <0.01). The obese T2D group had lower HOMA-β than the obese control group (P< 0.01). There was no significant difference in HOMA-IR between the obese T2D and obese control groups. The decline of β-cell function, together with persistent insulin resistance, accounts for the progression from normal glucose tolerance to T2D in obese people, while the decline in β-cell function mainly contributes to the progression in non-obese people.


会议专题>>>2015年美国糖尿病协会(ADA)年会

(本网站所有内容,凡注明来源为“医脉通”,版权均归医脉通所有,未经授权,任何媒体、网站或个人不得转载,否则将追究法律责任,授权转载时须注明“来源:医脉通”。本网注明来源为其他媒体的内容为转载,转载仅作观点分享,版权归原作者所有,如有侵犯版权,请及时联系我们。)

0
收藏 分享